BMEA · Biomea Fusion Inc. Common Stock
View on chartInsiders & Stakes
| Stergiopoulos Sotirios Director | ▲ Buy | Open Market | 4,400,000 Shares held | 9/17/2021 | View profile |
| Bihua Chen Chairperson and CEO | ▲ Buy | Open Market | 3,570,872 Shares held | 3/30/2023 | View profile |
| A2A Pharmaceuticals, Inc. 10% Owner | ▼ Sell | Open Market | 3,500,000 Shares held | 6/1/2023 | View profile |
| Rainer M. Erdtmann President & COO | ▲ Buy | Open Market | 723,027 Shares held | 12/11/2025 | View profile |
| Butler Thomas Andrew CEO | ▲ Buy | Open Market | 228,470 Shares held | 8/23/2021 | View profile |
| Michael J.M. Hitchcock Director | ▲ Buy | Open Market | 115,000 Shares held | 12/2/2025 | View profile |
| Franco Valle Chief Financial Officer | ▲ Buy | Grant | 42,995 Shares held | 11/30/2024 | View profile |
| Juan Pablo Frias Chief Medical Officer | ▲ Buy | Grant | 349 Shares held | 5/31/2024 | View profile |
| Biomea Health, LLC 10% Owner | ▼ Sell | Other | 0 Shares held | 6/1/2022 | View profile |
Transaction History
| Rainer M. Erdtmann | ▲ Buy | Open Market | 30,000 | $43K | 12/11/2025 |
| Michael J.M. Hitchcock | ▲ Buy | Open Market | 100,000 | $99K | 12/2/2025 |
| Rainer M. Erdtmann | ▲ Buy | Open Market | 10,000 | $11K | 12/1/2025 |
| Rainer M. Erdtmann | ▲ Buy | Open Market | 40,000 | $44K | 11/28/2025 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 10,000 | $0 | 1/31/2025 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 10,000 | $0 | 1/31/2025 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 10,000 | $0 | 1/31/2025 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 10,000 | $0 | 1/31/2025 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 10,000 | $0 | 1/31/2025 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 10,000 | $0 | 1/31/2025 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 40,000 | $0 | 1/28/2025 |
| Franco Valle | ▲ Buy | Grant | 495 | $3K | 11/30/2024 |
| Michael J.M. Hitchcock | ▲ Buy | Open Market | 10,000 | $101K | 9/30/2024 |
| Franco Valle | ▲ Buy | Open Market | 12,509 | $55K | 6/11/2024 |
| Franco Valle | ▲ Buy | Grant | 4,448 | $17K | 5/31/2024 |
| Juan Pablo Frias | ▲ Buy | Grant | 349 | $3K | 5/31/2024 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 3,000 | $0 | 12/29/2023 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 3,000 | $0 | 12/29/2023 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 3,000 | $0 | 12/29/2023 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 3,000 | $0 | 12/29/2023 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 3,000 | $0 | 12/29/2023 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 3,000 | $0 | 12/29/2023 |
| Rainer M. Erdtmann | ▼ Sell | Gift | 12,000 | $0 | 12/29/2023 |
| Franco Valle | ▲ Buy | Grant | 1,345 | $5K | 11/30/2023 |
| A2A Pharmaceuticals, Inc. | ▼ Sell | Open Market | 50,000 | $1.7M | 6/1/2023 |
| Franco Valle | ▲ Buy | Grant | 4,273 | $16K | 5/31/2023 |
| A2A Pharmaceuticals, Inc. | ▼ Sell | Open Market | 75,000 | $2.5M | 5/31/2023 |
| A2A Pharmaceuticals, Inc. | ▼ Sell | Open Market | 25,000 | $846K | 5/12/2023 |
| A2A Pharmaceuticals, Inc. | ▼ Sell | Open Market | 150,000 | $5.2M | 5/9/2023 |
| A2A Pharmaceuticals, Inc. | ▼ Sell | Open Market | 100,000 | $3.4M | 5/8/2023 |
| A2A Pharmaceuticals, Inc. | ▼ Sell | Open Market | 200,000 | $5.8M | 4/20/2023 |
| A2A Pharmaceuticals, Inc. | ▼ Sell | Open Market | 200,000 | $6.3M | 3/31/2023 |
| Bihua Chen | ▲ Buy | Open Market | 400,000 | $12.0M | 3/30/2023 |
| Franco Valle | ▲ Buy | Grant | 2,518 | $10K | 11/30/2022 |
| Michael J.M. Hitchcock | ▲ Buy | Open Market | 5,000 | $40K | 11/14/2022 |
| Franco Valle | ▲ Buy | Open Market | 4,100 | $31K | 11/11/2022 |
| A2A Pharmaceuticals, Inc. | ▲ Buy | Open Market | 30,684 | $426K | 8/16/2022 |
| A2A Pharmaceuticals, Inc. | ▼ Sell | Open Market | 34,658 | $389K | 7/21/2022 |
| A2A Pharmaceuticals, Inc. | ▼ Sell | Open Market | 34,658 | $408K | 6/24/2022 |
| Biomea Health, LLC | ▼ Sell | Other | 4,365,342 | $0 | 6/1/2022 |
| Franco Valle | ▲ Buy | Grant | 3,307 | $15K | 5/31/2022 |
| Franco Valle | ▲ Buy | Open Market | 10,000 | $87K | 1/14/2022 |
| Stergiopoulos Sotirios | ▲ Buy | Open Market | 34,658 | $380K | 9/17/2021 |
| A2A Pharmaceuticals, Inc. | ▲ Buy | Open Market | 34,658 | $380K | 9/17/2021 |
| Rainer M. Erdtmann | ▲ Buy | Open Market | 24,000 | $317K | 8/23/2021 |
| Butler Thomas Andrew | ▲ Buy | Open Market | 24,000 | $317K | 8/23/2021 |
| Rainer M. Erdtmann | ▲ Buy | Open Market | 14,000 | $151K | 8/18/2021 |
| Butler Thomas Andrew | ▲ Buy | Open Market | 14,000 | $151K | 8/18/2021 |
| Rainer M. Erdtmann | ▲ Buy | Open Market | 14,000 | $151K | 8/17/2021 |
| Butler Thomas Andrew | ▲ Buy | Open Market | 14,000 | $151K | 8/17/2021 |
| Rainer M. Erdtmann | ▲ Buy | Open Market | 176,470 | $3.0M | 4/15/2021 |
| Butler Thomas Andrew | ▲ Buy | Open Market | 176,470 | $3.0M | 4/15/2021 |